EB-1C Sustained — Pharmaceuticals (2023): the AAO found the Director's denial contained factual

Decision Summary

The appeal was sustained because the AAO found the Director's denial contained factual errors and insufficient reasoning. Upon de novo review, the AAO concluded that the petitioner successfully established the beneficiary was employed abroad and would be employed in the U.S. in a qualifying managerial capacity, specifically as a function manager overseeing an essential function.

Criteria Discussed

Sign up free to download the original PDF